IL152180D0 - Method and composition for treating cancer by administration of apoptosis-inducing chemotherapeutic agents - Google Patents

Method and composition for treating cancer by administration of apoptosis-inducing chemotherapeutic agents

Info

Publication number
IL152180D0
IL152180D0 IL15218001A IL15218001A IL152180D0 IL 152180 D0 IL152180 D0 IL 152180D0 IL 15218001 A IL15218001 A IL 15218001A IL 15218001 A IL15218001 A IL 15218001A IL 152180 D0 IL152180 D0 IL 152180D0
Authority
IL
Israel
Prior art keywords
apoptosis
administration
composition
method
chemotherapeutic agents
Prior art date
Application number
IL15218001A
Original Assignee
Teva Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US19592000P priority Critical
Application filed by Teva Pharma filed Critical Teva Pharma
Priority to PCT/US2001/011688 priority patent/WO2001076567A1/en
Publication of IL152180D0 publication Critical patent/IL152180D0/en

Links

IL15218001A 2000-04-10 2001-04-10 Method and composition for treating cancer by administration of apoptosis-inducing chemotherapeutic agents IL152180D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US19592000P true 2000-04-10 2000-04-10
PCT/US2001/011688 WO2001076567A1 (en) 2000-04-10 2001-04-10 Method and composition for treating cancer by administration of apoptosis-inducing chemotherapeutic agents

Publications (1)

Publication Number Publication Date
IL152180D0 true IL152180D0 (en) 2003-05-29

Family

ID=22723363

Family Applications (1)

Application Number Title Priority Date Filing Date
IL15218001A IL152180D0 (en) 2000-04-10 2001-04-10 Method and composition for treating cancer by administration of apoptosis-inducing chemotherapeutic agents

Country Status (19)

Country Link
US (1) US20020041888A1 (en)
EP (1) EP1274404A1 (en)
JP (1) JP2004507451A (en)
KR (1) KR20030008368A (en)
CN (1) CN1438882A (en)
AU (1) AU5333401A (en)
BR (1) BR0110150A (en)
CA (1) CA2406484A1 (en)
CZ (1) CZ20023333A3 (en)
EA (1) EA200201068A1 (en)
HU (1) HU0302296A2 (en)
IL (1) IL152180D0 (en)
MX (1) MXPA02009984A (en)
NO (1) NO20024867L (en)
PL (1) PL366035A1 (en)
SK (1) SK14452002A3 (en)
WO (1) WO2001076567A1 (en)
YU (1) YU77002A (en)
ZA (1) ZA200208167B (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20020680A1 (en) * 2002-03-29 2003-09-29 Acs Dobfar Spa improved antitumor Composition based on paclitaxel and method for obtaining it
ITMI20020681A1 (en) * 2002-03-29 2003-09-29 Acs Dobfar Spa Process for the production of nanoparticles of paclitaxel and albumin
EP1499299A2 (en) * 2002-04-26 2005-01-26 Teva Pharmaceutical Industries Ltd. Microparticle pharmaceutical compositions for intratumoral delivery
CN1319525C (en) * 2004-09-16 2007-06-06 北京圣医耀科技发展有限责任公司 Taxinol-sodium alginate micro ball vascular embolism agent and its preparation
KR100912307B1 (en) * 2004-10-21 2009-08-14 유니버시티 오브 아이오와 리써치 파운데이션 In situ controlled release drug delivery system
MX339142B (en) 2005-02-18 2016-05-13 Abraxis Bioscience Llc Combinations and modes of administration of therapeutic agents and combination therapy.
US8735394B2 (en) 2005-02-18 2014-05-27 Abraxis Bioscience, Llc Combinations and modes of administration of therapeutic agents and combination therapy
AU2006243337B2 (en) * 2005-05-04 2011-09-29 Syncore Biotechnology Co., Ltd Method of administering a cationic liposomal preparation comprising paclitaxel
ES2609388T3 (en) 2006-03-22 2017-04-20 Syncore Biotechnology Co., Ltd Treatment of triple negative breast cancer receptors
NZ717490A (en) 2010-03-29 2017-12-22 Abraxis Bioscience Llc Methods of treating cancer
NZ706745A (en) 2010-06-04 2017-01-27 Abraxis Bioscience Llc Methods of treatment of pancreatic cancer
WO2012094620A2 (en) * 2011-01-09 2012-07-12 Anp Technologies, Inc. Hydrophobic molecule-induced branched polymer aggregates and their use

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4345588A (en) * 1979-04-23 1982-08-24 Northwestern University Method of delivering a therapeutic agent to a target capillary bed
US4492720A (en) * 1983-11-15 1985-01-08 Benjamin Mosier Method of preparing microspheres for intravascular delivery
HU9701554D0 (en) * 1997-09-18 1997-11-28 Human Oltoanyagtermeloe Gyogys Pharmaceutical composition containing plazma proteins

Also Published As

Publication number Publication date
NO20024867D0 (en) 2002-10-09
WO2001076567A1 (en) 2001-10-18
EA200201068A1 (en) 2003-12-25
CN1438882A (en) 2003-08-27
BR0110150A (en) 2004-04-27
YU77002A (en) 2005-09-19
ZA200208167B (en) 2004-02-10
HU0302296A2 (en) 2003-10-28
KR20030008368A (en) 2003-01-25
PL366035A1 (en) 2005-01-24
CA2406484A1 (en) 2001-10-18
EP1274404A1 (en) 2003-01-15
AU5333401A (en) 2001-10-23
NO20024867L (en) 2002-12-06
US20020041888A1 (en) 2002-04-11
JP2004507451A (en) 2004-03-11
MXPA02009984A (en) 2004-09-10
CZ20023333A3 (en) 2003-06-18
SK14452002A3 (en) 2003-07-01

Similar Documents

Publication Publication Date Title
EG23769A (en) Treating composition
AP1727A (en) Methods and compositions for treating flavivirusesand pestiviruses
TWI342211B (en) Pharmaceutical composition comprising epothilone analogs for the treatment of cancer
HK1048949A1 (en) Method and composition for the treatment of scars
HU0400655A3 (en) Compositions containing inclusion complexes and process for their preparation
ZA200108285B (en) Antibody compositions and methods for cancer treatment by selectively inhibiting VEGF.
AU763954C (en) Compositions and methods for cancer treatment by selectively inhibiting VEGF
IL161775D0 (en) Topical compositions and methods for treatment of adverse effects ofionizing radiation
IL231810D0 (en) Maytansinoid derivatives and pharmaceutical compositions containing the same methods of producing the same and methods of use thereof for use in treating cancer
EP1575976A4 (en) Methods and compositions for therapeutic use of rna interference
AU7931301A (en) Method of using diketopiperazines and composition containing them
AU2001255516A1 (en) Methods and compositions for the prevention and treatment of anemia
EP1126841A4 (en) Method of treating migraines and pharmaceutical compositions
WO2002056912A3 (en) Pharmaceutical combination for the treatment of cancer containing a 4-quinazolineamine and another anti-neoplastic agent
AU2001260482A1 (en) Quinazoline derivatives for the treatment of tumours
HK1089364A1 (en) Topical compositions and methods for treating pain
AU2001270801A1 (en) Treatment of iron sulphide deposits
AU3497901A (en) Methods and compositions for treating conditions of the eye
AU2001290598A1 (en) Pharmaceutical composition and method for treating hypogonadism
PL211872B1 (en) Method of treatment using ligand-immunogen conjugates
GB0014969D0 (en) Novel method of treatment
PL356908A1 (en) Compositions and methods for the therapy and diagnosis of prostate cancer
GB0401948D0 (en) Topical composition for treating pain
AU2001277430A1 (en) Cyclopentanoindoles, compositions containing such compounds and methods of treatment
AU2002303626A1 (en) Composition and methods for treatment of hyperplasia